Related Experiment Video
Updated: Jan 10, 2026

Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model
Published on: January 21, 2018
Immune checkpoint inhibitor-induced myocarditis: a comprehensive review with clinical case insights
María José Santa-Ana-Bayona1, Camila Ponce-Acosta1, Edgar Quispe-Silvestre2
1Facultad Mexicana de Medicina, Universidad La Salle, Ciudad de México, México. Universidad La Salle Facultad Mexicana de Medicina Universidad La Salle Ciudad de México Peru.
Abstract:
Immune checkpoint inhibitors (ICIs) have revolutionized cancer therapy by significantly improving long-term outcomes across multiple malignancies. Despite their benefits, ICIs can lead to immune-related adverse events, including rare but severe cardiovascular toxicity such as myocarditis, which can be life-threatening. This comprehensive review aims to explore and discuss the mechanisms, clinical presentation, diagnostic challenges, and management strategies of ICI-induced myocarditis, emphasizing the need for early detection and timely intervention. As the use of ICIs continues to expand, further research is essential to fully elucidate the underlying mechanisms and optimize therapeutic strategies to mitigate this potentially fatal complication while maintaining the efficacy of cancer therapy.
More Related Videos
Related Concept Videos
Myocarditis III: Medical Management
Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis I: Introduction
Myocarditis IV: Nursing Management
Pericarditis III: Medical Management
Cardiomyopathy I: Introduction and Classification

